Archive - April 2020
Coronavirus In USA: Is It Time To Ease The Lockdowns?
FDA Approves Merck’s Keytruda (pembrolizumab) for Use at an Additional Recommended Dose of 400 mg Every Six Weeks for All Approved Adult Indications
Stock Your Cabinet With These Essentials During The COVID-19 Pandemic
Automating PV Data Capture: What’s Holding Companies Back?
Do Women Benefit From The Ketogenic Diet?
Moderna submits application to advance coronavirus vaccine testing
Sanofi, Regeneron challenge Keytruda with Libtayo lung data
Compass raises $80m for treatment-resistant depression drug based on magic mushrooms